Cited by 71Genetic Associations and EpidemiologyMultiple Sclerosis Research StudiesSystemic Lupus Erythematosus Research

Approaches and advances in the genetic causes of autoimmune disease and their implications

Open access
Inshaw, Jamie R. J., Cutler, Antony J., Burren, Oliver S., Stefana, M. Irina, Todd, John A.·2018·Nature Immunology

Abstract

Genome-wide association studies are transformative in revealing the polygenetic basis of common diseases, with autoimmune diseases leading the charge. Although the field is just over 10 years old, advances in understanding the underlying mechanistic pathways of these conditions, which result from a dense multifactorial blend of genetic, developmental and environmental factors, have already been informative, including insights into therapeutic possibilities. Nevertheless, the challenge of identifying the actual causal genes and pathways and their biological effects on altering disease risk remains for many identified susceptibility regions. It is this fundamental knowledge that will underpin the revolution in patient stratification, the discovery of therapeutic targets and clinical trial design in the next 20 years. Here we outline recent advances in analytical and phenotyping approaches and the emergence of large cohorts with standardized gene-expression data and other phenotypic data that are fueling a bounty of discovery and improved understanding of human physiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41590-018-0129-8

Cites

166 of 166 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • True pathogenic antigens causing the breakdown have not been identified for many autoimmune diseases, including rheumatoid arthritis and other tissue-specific disorders.

    “However, true pathogenic antigens causing the breakdown have not been identified for many autoimmune diseases, including RA and other tissue-specific disorders (229–231).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [229]

    The Pleiotropy section discusses genetic variants associated with rheumatoid arthritis, while Unchartered regions discusses unidentified candidate genes in type 1 diabetes. Neither addresses whether pathogenic antigens responsible for a breakdown of tolerance have been identified in rheumatoid arthritis or other tissue-specific disorders (searched: pathogenic antigens, autoantigens, breakdown of tolerance). (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 167 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [46]46. Inoshita, M. et al. Retraction: A significant causal association between Creactive protein levels and schizophrenia. Sci. Rep. 8, 46947 (2018).

Cited by

Sorted by citations

Authors
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I., & Todd, J. A.
Affiliations
  • Centre for Human Genetics (GB)
  • University of Cambridge (GB)
Corresponding author
Todd, John A.
Venue
Nature Immunology
Published
2018-06-20
Volume
19
Issue
7
Pages
674-684
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W2808397465
Cited by
70
References
167
Citations by year
2026: 1 · 2025: 5 · 2024: 7 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 14 · 2019: 8 · 2018: 2
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Wellcome Trust (107881/Z/15/Z)
  • National Institute for Health and Care Research (NF-SI-0513-10143)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
autoimmune disease, genetic susceptibility, polygenic risk, genome-wide association study, causal genes, disease mechanisms, gene expression data, patient stratification, therapeutic target, clinical trial design, environmental factors
MeSH terms
Autoimmune Diseases, Chromosome Mapping, Humans, Infections, Random Allocation, Genetic Variation, Sample Size, Genome-Wide Association Study, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review